Cardiovascular Disease and Risk Factors in PCOS Women of Postmenopausal Age: A 21-Year Controlled Follow-Up Study
The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
CONTEXT: Polycystic ovary syndrome (PCOS) is associated with the metabolic syndrome and, consequently, with a potentially increased risk of cardiovascular disease (CVD) and related mortality later in life. Studies regarding CVD and mortality in PCOS women well into the postmenopausal age are lacking. OBJECTIVE: Our objective was to examine whether postmenopausal PCOS women differ from controls regarding cardiovascular risk factors, myocardial infarction (MI), stroke and mortality. DESIGN AND SETTING: We conducted, at a university hospital, a prospective study of 35 PCOS women (61-79 yr) and 120 age-matched controls. The study was performed 21 yr after the initial study. PARTICIPANTS: Twenty-five PCOS women (Rotterdam criteria) and 68 controls participated in all examinations. Data on morbidity were based on 32 of 34 PCOS women and on 95 of 119 controls. INTERVENTIONS: INTERVENTIONS included reexamination, interviews, and data from the National Board of Health and Welfare and from the Hospital Discharge Registry. MAIN OUTCOME MEASURES: Blood pressure, glucose, insulin, triglycerides, total cholesterol, high- and low-density lipoprotein, apolipoprotein A1 and B, fibrinogen, and plasminogen activator inhibitor antigen were studied. Incidences of MI, stroke, hypertension, diabetes, cancer, cause of death, and age at death were recorded. RESULTS: PCOS women had a higher prevalence of hypertension (P = 0.008) and higher triglyceride levels (P = 0.012) than controls. MI, stroke, diabetes, cancer, and mortality prevalence was similar in the two cohorts with similar body mass index. CONCLUSIONS: The well-described cardiovascular/metabolic risk profile in pre- and perimenopausal PCOS women does not entail an evident increase in cardiovascular events during the postmenopausal period.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PCOS is linked with increased prevalence of cardiometabolic risk factors, including dyslipidemia [10,11,12,13], hypertension [13,14,15], chronic inflammation, and impaired glucose tolerance [16,17], as well as overweight and obesity [18,19].”
From Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS) (2023) · cites this paper as [13]
In the citing paper
“Women with PCOS experience increased cardiometabolic risk—including the metabolic syndrome, hypertension, insulin resistance, obesity and dyslipidemia—predisposing them to increased risk for diabetes and cardiovascular disease (CVD).2,10,17, 18, 19, 20”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [20]
In the citing paper
“The results regarding prevalence of T2DM in women with PCOS over the age of 40 years are conflicting.”
From Type 2 diabetes mellitus in women with polycystic ovary syndrome during a 24-year period: importance of obesity and abdominal fat distribution (2020) · cites this paper as Schmidt et al., 2011
In the citing paper
“The lack of significance might be due to the similar BMI between groups in that study and the fact that controls caught up in WHR during the 21-year follow-up period (Schmidt et al., 2011).”
From Type 2 diabetes mellitus in women with polycystic ovary syndrome during a 24-year period: importance of obesity and abdominal fat distribution (2020) · cites this paper as Schmidt et al., 2011
In the citing paper
“In our previous study of another cohort of women with PCOS and controls, where the women had a mean age of 72 years and similar BMI, the prevalence of T2DM was 22% for women with PCOS compared with 14% for controls (not statistically significant) (Schmidt et al., 2011).”
From Type 2 diabetes mellitus in women with polycystic ovary syndrome during a 24-year period: importance of obesity and abdominal fat distribution (2020) · cites this paper as Schmidt et al., 2011
Citations
Cites
1 retracted
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
RetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760 · cited 1×
“risk of diabetes mellitus, cardiovascular disease (CVD) (13) and all-cause mortality (14).”
BackgroundGerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (1957) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,208
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Walldius, G., Jungner, I., Holme, I., Aastveit, A. H., Kolar, W., & Steiner, E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07098-2 · Cited by 1,229
Wild, S., Pierpoint, T., McKeigue, P., & Jacobs, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01000.x · Cited by 970 · cited 6×
“Diabetes, a strong risk factor for CVD, as well as insulin resistance and hyperinsulinemia are common among PCOS women of premenopausal (2, 4) and perimenopausal/early postmenopausal age (9, 17).”
BackgroundResultInfluentialEndothelial and Antithrombotic Actions of HDL
Mineo, C., Deguchi, H., Griffin, J. H., & Shaul, P. W. (2006) · Circulation Research · doi:10.1161/01.res.0000225982.01988.93 · Cited by 655
Dahlgren, E., Janson, P. O., Johansson, S., Lapidus, L., & Odén, A. (1992) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.3109/00016349209006227 · Cited by 548
Self-citationWalldius, G., Jungner, I., Holme, I., Aastveit, A. H., Kolar, W., & Steiner, E. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00666-9 · Cited by 534
Dahlgren, E., Johansson, S., Lindstedt, G., Knutsson, F., Oden, A., Janson, P., Mattson, L.-A., Crona, N., & Lundberg, P.-A. (1992) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(92)90704-m · Cited by 527
Self-citationProfound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
Dunaif, A. E., Segal, K. R., Futterweit, W., et al. (1989) · Diabetes · doi:10.2337/diabetes.38.9.1165 · Cited by 518
Talbott, E. O., Guzick, D. S., Sutton-Tyrrell, K., McHugh-Pemu, K. P., Zborowski, J. V., Remsberg, K. E., & Kuller, L. H. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.11.2414 · Cited by 511
Mortality of Women with Polycystic Ovary Syndrome at Long-term Follow-up
Pierpoint, T., McKeigue, P. M., Isaacs, A. J., Wild, S. H., & Jacobs, H. S. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00035-3 · Cited by 504 · cited 1×
“A retrospective study in the United Kingdom of PCOS women demonstrated neither raised mortality (16) nor MI morbidity, despite a higher prevalence of metabolic risk factors and hypertension (17).”
BackgroundRisk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome
Conway, G. S., Agrawal, R., Betteridge, D. J., & Jacobs, H. S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02295.x · Cited by 427
Glueck, C. J., Papanna, R., Wang, P., Goldenberg, N., & Sieve-Smith, L. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00104-5 · Cited by 399
de Groot, P. C. M., Dekkers, O. M., Romijn, J. A., Dieben, S. W. M., & Helmerhorst, F. M. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr001 · Cited by 394
Syndrome X and Mortality: A Population-based Study
Trevisan, M., Liu, J., Bahsas, F. B., Menotti, A., & for the Risk Factor and Life Expectancy Research Group (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009572 · Cited by 388
Landin, K., Stigendal, L., Eriksson, E., Krotkiewski, M., Risberg, B., Tengborn, L., & Smith, U. (1990) · Metabolism · doi:10.1016/0026-0495(90)90164-8 · Cited by 342
Self-citationLong-term consequences of polycystic ovary syndrome: Results of a 31 year follow-up study
Wild, S., Pierpoint, T., Jacobs, H., & McKeigue, P. (2000) · Human Fertility · doi:10.1080/1464727002000198781 · Cited by 306
Pathophysiology and types of dyslipidemia in PCOS
Diamanti-Kandarakis, E., Papavassiliou, A. G., Kandarakis, S. A., & Chrousos, G. P. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.07.004 · Cited by 299
Elting, M. W., Korsen, T. J. M., Bezemer, P. D., & Schoemaker, J. (2001) · Human Reproduction · doi:10.1093/humrep/16.3.556 · Cited by 254
(2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm191 · Cited by 227
Valkenburg, O., Steegers-Theunissen, R. P. M., Smedts, H. P. M., Dallinga-Thie, G. M., Fauser, B. C. J. M., Westerveld, E. H., & Laven, J. S. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1756 · Cited by 201
Self-perceived psychological stress and incidence of coronary artery disease in middle-aged men
Rosengren, A., Tibblin, G., & Wilhelmsen, L. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90189-r · Cited by 192
Holte, J., Gennarelli, G., Berne, C., Bergh, T., & Lithell, H. (1996) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a019028 · Cited by 183
Eriksson, M., Holmgren, L., Janlert, U., Jansson, J.-H., Lundblad, D., Stegmayr, B., Söderberg, S., & Eliasson, M. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02312.x · Cited by 160
Mulders, A. G. M. G. J. (2004) · Human Reproduction · doi:10.1093/humrep/deh373 · Cited by 155
Mortality and Vascular Outcomes in Patients Treated for Thyroid Dysfunction
Flynn, R. W. V., MacDonald, T. M., Jung, R. T., Morris, A. D., & Leese, G. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1833 · Cited by 137
WILHELMSEN, L., JOHANSSON, S., ROSENGREN, A., WALLIN, I., DOTEVALL, A., & LAPPAS, G. (1997) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1997.00163.x · Cited by 136
Physical Activity, Physical Fitness and Risk of Myocardial Infarction1
Wilhelmsen, L., Tibblin, G., Aurell, M., BJURE, J., Ekström-Jodal, B., & Grimby, G. (2015) · Advances in cardiology · doi:10.1159/000399526 · Cited by 124
The association between polycystic ovaries and endometrial cancer
Pillay, O. C., Te Fong, L. F. W., Crow, J. C., Benjamin, E., Mould, T., Atiomo, W., Menon, P. A., Leonard, A. J., & Hardiman, P. (2006) · Human Reproduction · doi:10.1093/humrep/dei420 · Cited by 122
Schmidt, J., Brännström, M., Landin-Wilhelmsen, K., & Dahlgren, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2959 · Cited by 113 · cited 10×
“Finally, the lower prevalence of hypothyroidism during the postmenopausal period in PCOS women (18) could have a protective effect, because a relationship between hypothyroidism and CVD had been established (38).”
BackgroundMethodResultInfluentialSelf-citationPuurunen, J., Piltonen, T., Morin-Papunen, L., Perheentupa, A., Järvelä, I., Ruokonen, A., & Tapanainen, J. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0039 · Cited by 108 · cited 1×
“tion (33), where the HOMA index was increased in the 11”
BackgroundHemostatic and metabolic variables in women with polycystic ovary syndrome
Dahlgren, E., Janson, P. O., Johansson, S., Lapidus, L., Lindstedt, G., & Tengborn, L. (1994) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(94)90386-7 · Cited by 99
Self-citationCoagulation and Fibrinolytic Disturbances in Women with Polycystic Ovary Syndrome
Mannerås-Holm, L., Baghaei, F., Holm, G., Janson, P. O., Ohlsson, C., Lönn, M., & Stener-Victorin, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2279 · Cited by 93
Harmsen, P., Wilhelmsen, L., & Jacobsson, A. (2009) · Stroke · doi:10.1161/strokeaha.109.550814 · Cited by 77
Dotevall, A., Johansson, S., & Wilhelmsen, L. (1994) · Annals of Epidemiology · doi:10.1016/1047-2797(94)90071-x · Cited by 50
Sills, E. S., Drews‐Botsch, C., Perloe, M., Tucker, M. J., Kaplan, C. R., & Palermo, G. D. (2003) · Gynecological Endocrinology · doi:10.1080/gye.17.3.231.237 · Cited by 15
Cited by
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Epidemiology, diagnosis, and management of polycystic ovary syndrome
Sirmans, S., & Pate, K. (2013) · Clinical Epidemiology · doi:10.2147/clep.s37559 · Cited by 1,302
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
Sex differences in cardiovascular risk factors and disease prevention
Appelman, Y., van Rijn, B. B., ten Haaf, M. E., Boersma, E., & Peters, S. A. E. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.027 · Cited by 588
Metadata
- Authors
- Schmidt, J., Landin-Wilhelmsen, K., Brännström, M., & Dahlgren, E.
- Affiliations
- Sahlgrenska University Hospital (SE)
- Corresponding author
- Schmidt, Johanna
- ORCID
- Brännström, Mats
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-12
- Volume
- 96
- Issue
- 12
- Pages
- 3794-3803
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2166647497
- Cited by
- 241
- References
- 44
- Citations by year
- 2026: 10 · 2025: 8 · 2024: 11 · 2023: 22 · 2022: 24 · 2021: 16 · 2020: 17 · 2019: 14 · 2018: 15 · 2017: 18 · 2016: 11 · 2015: 21 · 2014: 26 · 2013: 13 · 2012: 14
- FWCI
- 19.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Västra Götalandsregionen
- Vetenskapsrådet
- Sahlgrenska Universitetssjukhuset
- Health and Medical Care Committee of the Regional Executive Board, Region Västra Götaland
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- polycystic ovary syndrome, postmenopausal women, cardiovascular disease, cardiovascular risk factors, hypertension, triglycerides, myocardial infarction, stroke, mortality, metabolic syndrome, long-term follow-up
- MeSH terms
- Adult, Aged, Blood Glucose, Blood Pressure, Cardiovascular Diseases, Cholesterol, Female, Follow-Up Studies, Humans, Insulin, Middle Aged, Polycystic Ovary Syndrome, Registries, Risk Factors, Triglycerides, Incidence, Prevalence, Postmenopause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.